KURIMOTO-EDUCATIONAL
20.4.2022 11:02:14 CEST | Business Wire | Press release
Kurimoto Educational Institute (KEI, Chairman: Dr. Hiroyuki Kurimoto), the parent organisation of the Nagoya University of Commerce (NUCB) received the official approval for the establishment of its boarding high school, NUCB International College (NIC).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220413006084/en/
World-Class Full Boarding High School in Japan
The plan to open the school in September 2022 is progressing as scheduled and NIC is now officially accepting applications from students around the world.
The co-educational institution is designed to provide a world-class education with excellent facilities and a rich natural environment, on its 200-acre campus, in Nisshin city, Japan.
School Outline
School Name: NUCB International College
Capacity: 225 students, Co-educational, Full boarding
Programme: Japanese Senior High School & International Baccalaureate Diploma Programme (IBDP)*
Year level range: 10-12. Student transfers accepted until Year 11.
Language of instruction: English
Location: 4-4 Sagamine, Komenoki, Nisshin, Aichi, Japan
Opening date: September 2022
*NUCB International College is a candidate school for the Diploma Programme. It is pursuing authorisation as an IB World School. Candidate status gives no guarantee that authorisation will be granted.
Educational excellence
NIC stands at the brink of an educational shift, being the only International Boarding High School in Japan implementing innovative early leadership education through the Harvard-style Case Method. Small classes enable personalised supervision by multinational faculty members with master's or doctoral degrees and faculty from affiliated business schools.
Boarding Education
With reference to international boarding school standards, boarding life is supported daily by House Supervisors and House Mentors. Through communal living in an international environment, participants learn the discipline and courtesy required of leaders in the context of diversity. NIC also offers a Summer School and the Bridging Programme (preparation for September enrolment). Plans are also underway for homestays, international exchange programmes, and cultural enrichment trips in Japan.
About Kurimoto Educational Institute
Parent organisation of NUCB Undergraduate School, NUCB Business School, and Nagoya International Junior and Senior High Schools, KEI promotes the high-quality internationalisation of education by acquiring international accreditations (AACSB, EQUIS, AMBA, and IBDP) for the schools it establishes, since 1935.
Click below to find out why NIC should be your number one choice for further studies.
https://ic.nucba.ac.jp/college/advantage/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220413006084/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom